| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.05 |